Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Irinotecan (CPT11) SN-38
Matrix: | Human Plasma |
Assay Range: | 2.00 - 2,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Irinotecan (CTP11) SN-38
Matrix: | Human Plasma |
Assay Range: | 2 - 4,000 ng/mL 2 - 4,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Iron (total)
Matrix: | Human Plasma |
Assay Range: | 50.0 - 5000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Lithium Heparin |
Storage Temperature (°C): | -20 & -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | |
Therapy Area: | |
Classification: | Drug Assays |
Iron (total) Iron (free)
Matrix: | Human Serum Ultrafiltrate |
Assay Range: | 2.00-5,000 ng/mL 2.00-150 ng/mL above native |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
Iron (total)
Iron (free)
Iron (free)
Matrix: | Human Serum |
Assay Range: | 2.00-5,000 ng/mL 2.00-150 ng/mL above native |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
Isoniazid
Matrix: | Human Plasma |
Assay Range: | 10 -4000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Sodium Heaprin |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Isosorbide
Mononitrate
Mononitrate
Matrix: | Human Plasma |
Assay Range: | 10 - 4,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Itraconazole
Matrix: | Human Plasma |
Assay Range: | 1 - 500 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antifungal |
Classification: | Drug Assays |
Itraconazole
Hydroxyl-Itraconazole
Hydroxyl-Itraconazole
Matrix: | Human Plasma |
Assay Range: | 1 - 500 ng/mL 2 - 1,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antifungal |
Classification: | Drug Assays |
Ketoconazole
Matrix: | Human Plasma |
Assay Range: | 20 - 10,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antifungal |
Classification: | Drug Assays |
Ketoprofen
Matrix: | Human Plasma |
Assay Range: | 50.0 - 15,000 ng/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | HPLC-UV |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | NSAID |
Classification: | Drug Assays |
Ketorolac
Matrix: | Human Plasma |
Assay Range: | 20 - 4,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Analgesic |
Classification: | Drug Assays |
Kidney injury molecule 1 (KIM-1)
Matrix: | Human Urine |
Assay Range: | 0.156 - 10.0 pg/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Kidney injury molecule 1 (KIM-1)
Matrix: | Human Urine |
Assay Range: | 50.0 - 2,000 pg/mL |
Sample Volume: | 0.125 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
KRAS (35G>T, 35G>A, 34G>T, 34G>A, 38G>A)
Matrix: | Human Whole Blood |
Assay Range: | N/A |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | Pyrosequencing |
Site: | QPS-Delaware |
CLIA: | |
Therapy Area: | |
Classification: | Genomic Biomarkers |
Lacosamide
Matrix: | Human Plasma |
Assay Range: | 40 - 12,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anticonvulsant |
Classification: | Genomic Biomarkers |
Lamivudine (3TC) Tenofovir (TFV) in presence of Dolutegravir (DTG), Efavirenz (EFV), and Emtricitabine (FTC)
Matrix: | Human Plasma |
Assay Range: | 15 - 6,000 ng/mL 2.5 - 1,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Lamivudine (3TC)
Tenofovir (TFV)
Tenofovir (TFV)
Matrix: | Human Plasma |
Assay Range: | 15 - 5,000 ng/mL 2 - 650 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Lamivudine (3TC)
Zalcitabine (ddC)
Zalcitabine (ddC)
Matrix: | Human Plasma |
Assay Range: | 1 - 1,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Lamotrigine
Matrix: | Human Plasma |
Assay Range: | 1 - 600 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Anticonvulsant |
Classification: | Drug Assays |
Lamotrigine
Matrix: | Human Plasma |
Assay Range: | 5 - 2,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anticonvulsant |
Classification: | Drug Assays |
Lamotrigine
Matrix: | Human Plasma |
Assay Range: | 5 - 4,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anticonvulsant |
Classification: | Drug Assays |
Lamotrigine
Matrix: | Human Plasma |
Assay Range: | 20 - 3,500 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anticonvulsant |
Classification: | Drug Assays |
Lamotrigine
Matrix: | Human Plasma |
Assay Range: | 5 - 1,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Anticonvulsant |
Classification: | Drug Assays |
Lansoprazole
Matrix: | Human Plasma |
Assay Range: | 5 - 2,250 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Gastrointestinal |
Classification: | Drug Assays |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT